|
MSN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.018300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77310000004649E-06 |
| Normal-vs-Stage2 |
5.186800E-01 |
| Normal-vs-Stage3 |
2.642100E-02 |
| Normal-vs-Stage4 |
8.638500E-02 |
| Stage1-vs-Stage2 |
6.799700E-03 |
| Stage1-vs-Stage3 |
5.217500E-02 |
| Stage1-vs-Stage4 |
2.571500E-02 |
| Stage2-vs-Stage3 |
2.710200E-01 |
| Stage2-vs-Stage4 |
4.460200E-01 |
| Stage3-vs-Stage4 |
6.747400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.53260000000222E-05 |
| Normal-vs-AfricanAmerican |
8.919200E-01 |
| Normal-vs-Asian |
1.980950E-01 |
| Caucasian-vs-AfricanAmerican |
2.717600E-03 |
| Caucasian-vs-Asian |
4.923000E-01 |
| AfricanAmerican-vs-Asian |
5.350000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.158500E-04 |
| Normal-vs-Female |
8.561500E-04 |
| Male-vs-Female |
8.600000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.220200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.50890000000437E-05 |
| Normal-vs-Age(61-80Yrs) |
7.224600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.587600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.265200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.797800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.264950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.927600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.371600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.226200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.37559999996628E-06 |
| Normal-vs-Grade 2 |
2.60969999998917E-06 |
| Normal-vs-Grade 3 |
1.368130E-02 |
| Normal-vs-Grade 4 |
1.718750E-01 |
| Grade 1-vs-Grade 2 |
4.108100E-02 |
| Grade 1-vs-Grade 3 |
4.196000E-03 |
| Grade 1-vs-Grade 4 |
3.258400E-03 |
| Grade 2-vs-Grade 3 |
1.533630E-02 |
| Grade 2-vs-Grade 4 |
1.916340E-02 |
| Grade 3-vs-Grade 4 |
5.620800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.01030000032587E-07 |
| Normal-vs-ccB subtype |
2.262100E-02 |
| ccA subtype-vs-ccB subtype |
2.239800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.799670E-03 |
| Normal-vs-N1 |
2.778000E-01 |
| N0-vs-N1 |
9.190200E-01 |
|
|
